| A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (NCT04978727) | Children's Oncology Group | 2022-07-01 |
| Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms (NCT04541082) | Jazz Pharmaceuticals | 2020-10-26 |
| INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas (NCT04295759) | Pediatric Brain Tumor Consortium | 2020-07-27 |
| Implantable Microdevice In Primary Brain Tumors (NCT04135807) | Oliver Jonas | 2020-03-03 |
| Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas (NCT04623931) | M.D. Anderson Cancer Center | 2020-01-30 |
| Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas (NCT03971734) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-12-06 |
| Pediatric Long-Term Follow-up and Rollover Study (NCT03975829) | Novartis Pharmaceuticals | 2019-11-04 |
| SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors (NCT03434262) | St. Jude Children's Research Hospital | 2018-03-05 |
| Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma (NCT03180502) | NRG Oncology | 2018-01-23 |
| Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors (NCT02684058) | Novartis Pharmaceuticals | 2017-12-28 |
| NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma (NCT03353896) | University of Southern California | 2017-12-15 |
| Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children (NCT03043391) | Istari Oncology, Inc. | 2017-11-07 |
| Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma (NCT03072134) | Northwestern University | 2017-04-24 |
| RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas (NCT02871843) | EpicentRx, Inc. | 2017-02-14 |
| Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma (NCT02101905) | National Cancer Institute (NCI) | 2016-11-07 |
| Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors (NCT02644291) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-05-01 |
| Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas (NCT02238496) | Andrew B Lassman, MD | 2014-12-08 |
| Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma (NCT02168270) | University of Nebraska | 2014-06-16 |
| Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor (NCT01985256) | Tocagen Inc. | 2014-02-01 |
| Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas (NCT01849952) | Dartmouth-Hitchcock Medical Center | 2013-10-09 |
| p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors (NCT01975116) | Pediatric Brain Tumor Consortium | 2013-08-01 |
| Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas (NCT01721577) | Rush University Medical Center | 2012-12-01 |
| Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma (NCT01250470) | Roswell Park Cancer Institute | 2012-09-05 |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma (NCT01656980) | Shandong Lanjin Pharmaceuticals Co.,Ltd | 2012-08-01 |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma (NCT01637753) | Shandong Lanjin Pharmaceuticals Co.,Ltd | 2012-06-01 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820) | Roswell Park Cancer Institute | 2012-03-01 |
| Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor (NCT01470794) | Tocagen Inc. | 2012-02-01 |
| AZD8055 for Adults With Recurrent Gliomas (NCT01316809) | National Cancer Institute (NCI) | 2011-03-04 |
| (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas (NCT01281982) | National Cancer Institute (NCI) | 2011-01-13 |
| A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma (NCT01156584) | Tocagen Inc. | 2010-07-01 |
| Cellular Immunotherapy Study for Brain Cancer (NCT01144247) | Jonsson Comprehensive Cancer Center | 2010-07-01 |
| Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 (NCT01082926) | City of Hope Medical Center | 2010-05-01 |
| A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas (NCT00995007) | National Cancer Institute (NCI) | 2009-09-01 |
| Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma (NCT00734864) | Annick Desjardins | 2009-06-01 |
| Sorafenib in Newly Diagnosed High Grade Glioma (NCT00884416) | University Hospital, Geneva | 2009-03-01 |
| Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma (NCT01095094) | Case Comprehensive Cancer Center | 2009-01-01 |
| Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors (NCT00667394) | National Cancer Institute (NCI) | 2008-04-01 |
| Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme. (NCT00645385) | Weill Medical College of Cornell University | 2007-06-01 |
| Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00390299) | Mayo Clinic | 2006-10-23 |
| Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors (NCT00303849) | OHSU Knight Cancer Institute | 2005-09-15 |
| Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma (NCT00362570) | Ohio State University Comprehensive Cancer Center | 2005-05-01 |
| Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas (NCT00062504) | Teva Branded Pharmaceutical Products R&D, Inc. | 2003-07-01 |
| Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma (NCT00064779) | INSYS Therapeutics Inc | 2003-07-01 |
| Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms (NCT00004688) | Emory University | 1996-08-01 |
| Expanded Access to ANG1005 for Individual Patients (NCT02755987) | Angiochem Inc | |